Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2026 11:12 ET | Source: Research and Markets

$18.67 Bn MASH Treatment Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029 & 2034

Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "MASH Treatment Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The comprehensive analysis of the...
January 05, 2026 08:00 ET | Source: Compass Therapeutics

Compass Therapeutics Announces Key Leadership Appointments

BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
January 02, 2026 21:07 ET | Source: Westhaven Gold Corp.

Westhaven Closes CDN$3 Million Private Placement with Dundee Corporation

VANCOUVER, British Columbia, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (“Westhaven” or the “Company”) is pleased to announce that it has closed its previously announced...
December 31, 2025 19:41 ET | Source: HUMBL, Inc.

HUMBL Announces Corporate Rebrand to TAP Real Estate Technologies, Inc.

Salt Lake City, UT, Dec. 31, 2025 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTC: HMBL) today announced that it has initiated a strategic corporate rebrand to TAP Real Estate Technologies, Inc. (“TAP Real...
December 31, 2025 10:36 ET | Source: Pain2Power Coaching

Dr. Keith Ablow Unveils “26 Ways to Change Your Life in 2026” — A Bold Blueprint for Personal Transformation

Dr. Keith Ablow Unveils “26 Ways to Change Your Life in 2026”
December 29, 2025 21:24 ET | Source: Prostadine

Prostadine Drops Ingredient Analysis 2026: Examining the Science Behind the Liquid Prostate Wellness Formula

New 2026 analysis examines Prostadine drops' nine marine-derived ingredients, iodine content, saw palmetto research, and safety considerations for men.
December 24, 2025 09:30 ET | Source: Westhaven Gold Corp.

Westhaven Announces Grant of Incentive Stock Options and Peterson Capital Engagement

VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (“Westhaven” or the “Company”) announces that, pursuant to the terms of the Company's Stock Option...
December 24, 2025 09:15 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth

Vancouver, Canada, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery...
December 22, 2025 16:35 ET | Source: HUMBL, Inc.

U.S. District Court Dismisses Securities Class Action Against HUMBL, Inc.

San Diego, California, Dec. 22, 2025 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTC: HMBL) today announced that the United States District Court for the District of Delaware has dismissed, with prejudice, the...
December 22, 2025 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors

MADRID and CAMBRIDGE, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics,...